- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0017967

About Medilief Biosciences Private Limited
Data last updated:
Medilief Biosciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2011PTC226072. Its GSTIN is 07AABCO6043K1ZD (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Onconep Healthcare Private Limited. It is led by directors Vikas Kumar Goel and Nandini Goel.
Its last annual general meeting (AGM) was held on 30 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Office No. 215 Ansal Classique Tower Plot No. 1 J – Block Community Centre Rajouri Garden, New Delhi, Delhi, India – 110027.
As per the financials filed for FY 2026, the company reported a revenue of ₹5.42 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹7.93 Lakh (net margin 1.5%) and EBITDA of ₹29.06 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over five years.
As per MCA filings, the company has open charges of ₹1.05 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Medilief Biosciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0017967). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medilief.com.
Company details
Recognitions & Rankings of Medilief Biosciences
Contact details
Medilief Biosciences Private Limited's registered office is in New Delhi, Delhi. Its website is medilief.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No. 215 Ansal Classique Tower Plot No. 1 J – Block Community Centre Rajouri Garden, New Delhi, Delhi, India – 110027
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medilief Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medilief Biosciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Medilief Biosciences Private Limited, buy the company report.
Financials of Medilief Biosciences Private Limited
FY 2026 filings availableMedilief Biosciences Private Limited reported revenue of ₹5.42 Cr (down 2% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹5.42 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.93 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medilief Biosciences Private Limited, buy the company report.
Board of directors of Medilief Biosciences Private Limited
Medilief Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Kumar Goel | Director | 15 Jul 2013 | 13 Years 4 Months | Current |
| Nandini Goel | Director | 11 Oct 2011 | 15 Years 1 Months | Current |
Auditor
Medilief Biosciences Private Limited is audited by GARG & AGARWAL for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG & AGARWAL | FY 2026 | 020073N |
Shareholding
The shareholding of Medilief Biosciences Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medilief Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2026 | 101366956 | The South Indian Bank Limited | ₹5.38 Lakh | Open | |
| 21 Aug 2025 | 101154626 | The South Indian Bank Limited | ₹1 Cr | Open |
To see the full charge records of Medilief Biosciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Medilief Biosciences Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Civil suit | Filed against the company by State | Disposed |
To see the full case history of Medilief Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medilief Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medilief Biosciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCO6043K1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medilief Biosciences Private Limited, buy the company report.
Recent activity
Medilief Biosciences Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Ganesh Dayal ceased to be Director on 20 Jul 2013.
Frequently asked questions
Medilief Biosciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 October 2011 (15+ years old) and is registered under CIN U74900DL2011PTC226072.
Medilief Biosciences has 2 current directors:
- Vikas Kumar Goel - Director
- Nandini Goel - Director
The latest financial statements of Medilief Biosciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Medilief Biosciences is 07AABCO6043K1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Medilief Biosciences is U74900DL2011PTC226072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medilief Biosciences has 1 court case on record: 1 filed against it.
Medilief Biosciences was incorporated on 11 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Ganesh Dayal ceased to be Director on 20 Jul 2013. Vikas Kumar Goel was appointed as Director on 15 Jul 2013. Nandini Goel was appointed as Director on 11 Oct 2011.
Yes, Medilief Biosciences is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0017967).
Medilief Biosciences can be reached through the website medilief.com. Its registered office is in New Delhi, Delhi, India.

